Diffusion Pharmaceuticals Stock News

Second of Three TSC Oxygenation Trials Second of Three TSC Oxygenation Trials

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) was the recipient of a significant growth in short interest in the month of October. As of October 29th, there was short interest totalling 727,800 shares, a growth of 19.4% from the October 14th total of 609,700 shares. Based on an average trading volume of 982,900 shares, the days-to-cover ratio is []

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN)’s traded shares stood at 2.34 million during the latest session, with the company’s beta value hitting 1.45. At the last check today, the stock’s price was $0.40, to imply an increase of 2.52% or $0.01 in intraday trading. The DFFN share’s 52-week high remains $1.85, putting it -362.5% down since that … Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Plunging -42.71% In 6 Months – Here’s What To Expect Read More »

With a new year fast approaching, these biotech penny stocks may benefit from the shifting winds in the broader healthcare market. The post 7 Biotech Penny Stocks With Huge Catalysts Coming in 2022 ap

CHARLOTTESVILLE, Va., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel

Conference to Take Place Virtually, September 13-15, 2021 Conference to Take Place Virtually, September 13-15, 2021

The stock price of Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) increased by over 7% pre-market. This is why it happened.

Phase 2 DLCO Trial in Interstitial Lung Disease Expected to Begin in Q4 Under New IND

CHARLOTTESVILLE, Va., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel

Does your list of penny stocks to watch include these 7 hot small-caps? The post Making a List of Penny Stocks to Buy?

Are these trending penny stocks worth adding to your watchlist? The post 7 Trending Penny Stocks That You Need to Know About in July 2021 appeared first on Penny Stocks to Buy, Picks, News and Informa

Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) has announced topline results from the Phase 1 trial of its lead product candidate, trans sodium crocetinate (TSC). In the trial, transcutaneous oxygen

Trial Dosed Healthy Volunteers with Trans Sodium Crocetinate Trial Dosed Healthy Volunteers with Trans Sodium Crocetinate

Presentation Scheduled for June 24, 2021 at 11:30 a.m., EDT Presentation Scheduled for June 24, 2021 at 11:30 a.m., EDT

Annual Meeting Scheduled for June 25, 2021, at 1 p.m. EDT Annual Meeting Scheduled for June 25, 2021, at 1 p.m. EDT